Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AUPH

Aurinia Pharmaceuticals Inc

Jun 08 • 04:00PM ET

15.66

-0.18 -1.14 %

Healthcare • Biotechnology • Canada • Mid • NASD

Peers: MIRM PTCT RYTM VKTX BMRN INCY KRYS AXSM NBIX PHVS

| Held by: IWM IWO IBB VTWO JSMD VHT FESM AVSC JSML PSC

Scroll to Statements

Index	RUT	P/E	7.24	EPS (ttm)	2.16	Insider Own	11.71%	Shs Outstand	130.77M	Perf Week	2.29%
Market Cap	2.01B	Forward P/E	12.67	EPS next Y	1.24	Insider Trans	12.85%	Shs Float	113.54M	Perf Month	3.43%
Enterprise Value	1.70B	PEG	-	EPS next Q	0.24	Inst Own	61.70%	Short Float	7.95%	Perf Quarter	8.98%
Income	298.21M	P/S	6.75	EPS this Y	-53.62%	Inst Trans	1.51%	Short Ratio	7.53	Perf Half Y	2.29%
Sales	298.30M	P/B	3.61	EPS next Y	28.75%	ROA	48.54%	Short Interest	9.02M	Perf YTD	-1.82%
Book/sh	4.34	P/C	5.32	EPS next 5Y	-4.55%	ROE	64.98%	52W High	16.88 -7.23%	Perf Year	91.21%
Cash/sh	2.95	P/FCF	12.06	EPS past 3/5Y	- -	ROIC	48.24%	52W Low	7.28 114.96%	Perf 3Y	50.43%
Dividend Est.	-	EV/EBITDA	11.40	Sales past 3/5Y	28.30% 41.38%	Gross Margin	89.74%	Volatility	4.36% 3.70%	Perf 5Y	25.48%
Dividend TTM	-	EV/Sales	5.71	EPS Y/Y TTM	696.05%	Oper. Margin	43.58%	ATR (14)	0.61	Perf 10Y	443.75%
Dividend Ex-Date	-	Quick Ratio	5.01	Sales Y/Y TTM	20.62%	Profit Margin	99.97%	RSI (14)	50.68	Recom	2.14
Dividend Gr. 3/5Y	- -	Current Ratio	5.55	EPS Q/Q	53.13%	SMA20	0.31%	Beta	1.42	Target Price	17.00
Payout	0.00%	Debt/Eq	0.12	Sales Q/Q	24.40%	SMA50	-0.00%	Rel Volume	0.65	Prev Close	15.84
Employees	128	LT Debt/Eq	0.09	Earnings	May 07 BMO	SMA200	8.55%	Avg Volume	1.20M	Price	15.66
IPO	Oct 20, 2003	Option/Short	Yes / Yes	EPS/Sales Surpr.	28.21% 0.94%	Trades		Volume	783,621	Change	-1.14%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)